DMK PHARMACEUTICALS Corp reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
DMK PHARMACEUTICALS Corp has filed 1,210 SEC EDGAR filings since 13 Feb 1996

SEC filing history

Showing 126-150 of 775 matching filings.

Per page
25
Current page
6
10-Q File 001-36242

QUARTERLY REPORT

Filing date
16 May 2022
Reporting date
31 Mar 2022
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
09 May 2022
Reporting date
03 May 2022
Next action
Verify source filing
10-K/A File 001-36242

AMENDMENT TO FORM 10-K

Filing date
02 May 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
11 Apr 2022
Reporting date
07 Apr 2022
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
31 Mar 2022
Reporting date
31 Mar 2022
Next action
Verify source filing
10-K File 001-36242

ANNUAL REPORT

Filing date
31 Mar 2022
Reporting date
31 Dec 2021
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
28 Mar 2022
Reporting date
21 Mar 2022
Next action
Verify source filing
4

4 filing

Filing date
22 Mar 2022
Reporting date
18 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Mar 2022
Reporting date
18 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Mar 2022
Reporting date
18 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Mar 2022
Reporting date
18 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
03 Mar 2022
Reporting date
25 Feb 2022
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
18 Feb 2022
Reporting date
15 Feb 2022
Next action
Verify source filing
5

FORM 5 - MARGUGLIO

Filing date
14 Feb 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
10 Jan 2022
Reporting date
10 Jan 2022
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
04 Jan 2022
Reporting date
31 Dec 2021
Next action
Verify source filing
4

4 filing

Filing date
03 Dec 2021
Reporting date
01 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Dec 2021
Reporting date
01 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Dec 2021
Reporting date
01 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Dec 2021
Reporting date
01 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
23 Nov 2021
Reporting date
23 Nov 2021
Next action
Verify source filing
10-Q File 001-36242

QUARTERLY REPORT

Filing date
22 Nov 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
22 Nov 2021
Reporting date
22 Nov 2021
Next action
Verify source filing
10-Q File 001-36242

QUARTERLY REPORT

Filing date
22 Nov 2021
Reporting date
31 Mar 2021
Next action
Verify source filing
10-Q File 001-36242

QUARTERLY REPORT

Filing date
22 Nov 2021
Reporting date
30 Sep 2021
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .